BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28687251)

  • 1. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
    Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
    Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elafin as a Predictive Biomarker of Acute Skin Graft-
    Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
    Front Immunol; 2021; 12():516078. PubMed ID: 33679728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombotic complications after hematopoietic stem cell transplantation].
    Nomura S
    Rinsho Ketsueki; 2017; 58(5):516-522. PubMed ID: 28592769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide.
    Solán L; Kwon M; Carbonell D; Dorado N; Balsalobre P; Serrano D; Chicano-Lavilla M; Anguita J; Gayoso J; Díez-Martín JL; Martínez-Laperche C; Buño I
    Front Immunol; 2019; 10():2338. PubMed ID: 31649665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
    Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
    J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
    Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
    Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
    Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
    Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?
    Öztürk G; Bayrakoğlu D; Haskoloğlu Ş; Baskın K; Deveci N; İnce E; İleri T; Çakmaklı H; Ertem M; İkincioğulları A; Doğu F
    Hematol Transfus Cell Ther; 2024 Apr; ():. PubMed ID: 38658297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in protein serum levels during stem cell transplantation.
    Metafuni E; Giammarco S; De Ritis DG; Rossi M; Corrente F; Piccirillo N; Bacigalupo AP; Sica S; Chiusolo P
    Eur J Clin Invest; 2017 Oct; 47(10):711-718. PubMed ID: 28796281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
    Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
    Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
    Holtan SG; Verneris MR; Schultz KR; Newell LF; Meyers G; He F; DeFor TE; Vercellotti GM; Slungaard A; MacMillan ML; Cooley SA; Blazar BR; Panoskaltsis-Mortari A; Weisdorf DJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1029-36. PubMed ID: 25759146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
    Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
    Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarkers for acute graft-versus-host disease risk after cyclophosphamide-fludarabine nonmyeloablative allotransplantation.
    Nelson RP; Khawaja MR; Perkins SM; Elmore L; Mumaw CL; Orschell C; Paczesny S
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1861-4. PubMed ID: 25017764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation.
    Ayuk F; Bussmann L; Zabelina T; Veit R; Alchalby H; Wolschke C; Lellek H; Bacher U; Zander AR; Kröger N
    Ann Hematol; 2014 May; 93(5):855-61. PubMed ID: 24248672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
    Liu H; Chen Y; Xuan L; Wu X; Zhang Y; Fan Z; Huang F; Zhang X; Jiang Q; Sun J; Liu Q
    Acta Haematol; 2013; 130(3):160-8. PubMed ID: 23711991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation.
    Nomura S; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Satake A; Katayama Y; Ohta S; Hayashi K; Ishii K; Ito T
    Transpl Immunol; 2019 Dec; 57():101247. PubMed ID: 31666188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.